Furthermore, following separation ofspheroids into CD133+ and CD133− cells, PI3K inhibition withLY294002 reduced the expression of CD133 and Nanog in CD133+ cells fromall sarcoma lines (Suppl. Here, PROM1 is linked to sarcoma.